The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

Compounded GLP-1s are no longer to be sold following the FDA announcement that the shortage of semaglutide and tirzepatide ended.

A San Antonio weight loss clinic owner is encouraging consumers of the GLP-1 drug semaglutide not to panic now that the FDA ...

Compounding pharmacies, that produced the weight loss drugs at a fraction of their brand name price, are being forced to stop ...

We've all heard about Ozempic — a medication that treats diabetes but is largely used to lose weight. But not everyone does ...

The recent dismissal of 13 FDA review staff eliminated precisely the kind of government spending that delivered the most bang ...

For weight loss, weight management, and overall wellness, focus on eating healthy foods, like high-protein meals, legumes, ...

Ozempic is an injectable semaglutide medication approved by the Food and Drug Administration (FDA) to help manage type 2 diabetes and assist in blood sugar management, alongside lifestyle changes.

In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.

Marty Makary had his first television interview since Trump's Make America Healthy Again Commission released its assessment on childhood chronic diseases.